AXIM
Price:
$0.0016
Market Cap:
$483.13K
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing...[Read more]
Industry
Biotechnology
IPO Date
2014-09-02
Stock Exchange
PNK
Ticker
AXIM
According to AXIM Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current ROE is 54.15%. This represents a change of 359.41% compared to the average of 11.79% of the last 4 quarters.
The mean historical ROE of AXIM Biotechnologies, Inc. over the last ten years is 172.36%. The current 54.15% ROE has changed -68.58% with respect to the historical average. Over the past ten years (40 quarters), AXIM's ROE was at its highest in in the March 2020 quarter at 560.77%. The ROE was at its lowest in in the June 2021 quarter at -368.82%.
Average
172.36%
Median
108.16%
Minimum
-429.85%
Maximum
706.45%
Discovering the peaks and valleys of AXIM Biotechnologies, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 493.10%
Maximum Annual ROE = 706.45%
Minimum Annual Increase = -529.15%
Minimum Annual ROE = -429.85%
Year | ROE | Change |
---|---|---|
2023 | 105.26% | -14.73% |
2022 | 123.45% | -82.53% |
2021 | 706.45% | -264.35% |
2020 | -429.85% | -529.15% |
2019 | 100.16% | -9.81% |
2018 | 111.06% | 67.45% |
2017 | 66.33% | -72.93% |
2016 | 244.98% | -58.85% |
2015 | 595.37% | 493.10% |
2014 | 100.38% | 5.67% |
The current ROE of AXIM Biotechnologies, Inc. (AXIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
311.72%
5-year avg
121.09%
10-year avg
172.36%
AXIM Biotechnologies, Inc.’s ROE is greater than Cellectis S.A. (-75.49%), greater than Biotron Limited (-423.05%), greater than Regenicin, Inc. (0%), greater than Bioasis Technologies Inc. (0%), less than Adynxx, Inc. (0%), greater than Ascletis Pharma Inc. (0%), greater than Wesana Health Holdings Inc. (-11.43%), less than BioVaxys Technology Corp. (255.46%), less than GH Research PLC (322.77%), greater than Algernon Pharmaceuticals Inc. (-20.29%), greater than Mindset Pharma Inc. (-131.40%), greater than Biostage, Inc. (-316.80%), greater than BioCardia, Inc. (-129.88%), less than AVAX Technologies, Inc. (1.00%), greater than null (-344.15%),
Company | ROE | Market cap |
---|---|---|
-75.49% | $183.12M | |
-423.05% | $9.11M | |
0% | $15.35K | |
0% | $27.62M | |
0% | $600.00 | |
0% | $242.35M | |
-11.43% | $206.34K | |
255.46% | $11.79M | |
322.77% | $369.01M | |
-20.29% | $964.52K | |
-131.40% | $54.51M | |
-316.80% | $57.82M | |
-129.88% | $10.12K | |
1.00% | $6.89K | |
-344.15% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AXIM Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AXIM Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AXIM Biotechnologies, Inc.'s ROE?
How is the ROE calculated for AXIM Biotechnologies, Inc. (AXIM)?
What is the highest ROE for AXIM Biotechnologies, Inc. (AXIM)?
What is the 3-year average ROE for AXIM Biotechnologies, Inc. (AXIM)?
What is the 5-year average ROE for AXIM Biotechnologies, Inc. (AXIM)?
How does the current ROE for AXIM Biotechnologies, Inc. (AXIM) compare to its historical average?